Paul Cate
Algemeen Directeur bij Mark IV Capital, Inc.
Profiel
Paul M.
Cate is currently the Chief Executive Officer at Mark IV Capital, Inc. since 1998 and the Chairman of the Board at PhageTech, Inc. since 2016.
He has an undergraduate degree from The California State University and a graduate degree from Golden Gate University.
Actieve functies van Paul Cate
| Bedrijven | Functie | Begin |
|---|---|---|
Mark IV Capital, Inc.
 Mark IV Capital, Inc. Investment ManagersFinance Mark IV Capital, Inc. is a real estate, private equity and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. | Algemeen Directeur | 01-12-1998 |
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Voorzitter | 01-03-2016 |
Opleiding van Paul Cate
| The California State University | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Mark IV Capital, Inc.
Mark IV Capital, Inc. Investment ManagersFinance Mark IV Capital, Inc. is a real estate, private equity and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. | Finance |
PhageTech, Inc.
PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Commercial Services |